Skip to Main Content
Contribute Try STAT+ Today

In harsh tones, U.S. regulators warned a Minnesota hospital and two of its physicians for violating regulations on human research in studies that tested antipsychotics and the potent anesthetic ketamine on patients in emergency rooms or prior to their arrival.

The warnings were issued by the Food and Drug Administration after its inspectors found Hennepin County Medical Center and the physicians failed to obtain consent from subjects for trials that involved testing the safety and effectiveness of the medications for managing agitation. The inspections took place in April 2019 and the FDA letters were sent last May, but only became publicly available this week.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Create a display name to comment

This name will appear with your comment